Martin Roper, Chief Executive Officer of Vita Coco (COCO 1.60%), reported the sale of 25,000 shares of common stock for a total of approximately $1.25 million, as disclosed in a SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold (direct) | 25,000 |
| Transaction value | $1.25 million |
| Post-transaction shares (direct) | 298,484 |
| Post-transaction shares (indirect) | 689,093 |
| Post-transaction value (direct ownership) | ~$14.42 million |
Transaction value based on SEC Form 4 weighted average purchase price ($50.00); post-transaction value based on April 16, 2026 market close ($48.33).
Key questions
- What was the mechanism behind this transaction, and how does it affect Roper’s equity exposure?
The sale involved the exercise of 25,000 vested stock options with the resulting shares immediately sold, converting derivative exposure into realized proceeds while leaving Roper with 298,484 common shares directly held and substantial unexercised options for future liquidity. - How does the trade relate to recent holding patterns and available capacity?
Recent sales have reduced Roper’s direct equity position by more than 74% since October 2025; smaller trade sizes in this period reflect a diminished available share pool rather than a discretionary reduction in sale cadence. - What is the context for indirect holdings and ongoing ownership?
Roper continues to hold 689,093 shares via family trusts, confirming that this transaction impacts only a portion of his total beneficial interest. - How does the sale align with valuation and market conditions?
The sale was executed at around $50 per share, with Vita Coco's stock up 52.48% over the past year as of April 16, 2026, suggesting the transaction monetizes appreciation in a favorable market environment under a pre-established Rule 10b5-1 plan.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $609.78 million |
| Net income (TTM) | $71.32 million |
| Employees | 319 |
| 1-year price change | 52.48% |
* 1-year performance calculated using April 16, 2026 as the reference date.
Company snapshot
- Vita Coco offers coconut water, coconut oil, coconut milk, hydration drink mixes, sparkling water, plant-based energy drinks, purified water, and protein-infused fitness drinks under brands such as Vita Coco, Runa, Ever & Ever, and PWR LIFT.
- It generates revenue through the development, marketing, and distribution of branded non-alcoholic beverages, primarily leveraging retail, club, convenience, e-commerce, and foodservice channels.
- The company targets health-conscious consumers in the United States and international markets, with distribution spanning North America, Europe, the Middle East, and Asia Pacific.
The Vita Coco Company is a leading provider in the non-alcoholic beverage sector, specializing in coconut water and related hydration products. With a focused portfolio of innovative brands, the company leverages a multi-channel distribution strategy to reach a broad, health-oriented customer base.
What this transaction means for investors
The April 16 sale of 25,000 Vita Coco shares by CEO Martin Roper is not a red flag for investors. He executed the transaction as part of a Rule 10b5-1 trading plan. Such plans are often adopted by insiders to avoid accusations of making trades based on insider information. Moreover, Roper still possessed about one million directly and indirectly-held shares after the sale, suggesting he is not in a rush to dispose of his stock.
Roper’s disposition came at a time when Vita Coco shares had taken off. The stock hit a 52-week high of $61.39 in March, thanks to strong business performance.
Vita Coco ended 2025 with full-year revenue of $609.8 million, up 18% year over year due to strong 26% sales growth in its flagship Vita Coco Coconut Water drink compared to 2024. The company expects revenue to continue rising in 2026, reaching between $680 million to $700 million.
Vita Coco’s excellent performance and expected sales growth suggest the stock is a worthwhile investment. However, its shares have a forward price-to-earnings ratio of around 30, which is not cheap. This makes now a good time for shareholders to sell, but those wanting to buy the stock may want to wait for the price to drop.
